Status:
COMPLETED
Effectiveness of Nalbuphine as an Adjuvant to Subarachnoid Block on Postoperative Analgesia in TURP Surgery
Lead Sponsor:
Chulalongkorn University
Conditions:
Transurethral Resection of Prostate
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare pain after surgery in patients undergoing Transurethral Resection of Prostate. The main question it aims to answer are: Intrathecal nalbuphine as an adjuv...
Detailed Description
This study aims to evaluate the efficacy and side effects of nalbuphine, with the goal of providing anesthesiologists with evidence-based guidance for selecting the most appropriate pharmacological ag...
Eligibility Criteria
Inclusion
- Patients scheduled for Transurethral Resection of Prostate under spinal anesthesia
- American Society of Anesthesiologists (ASA) physical status I-III
Exclusion
- Allergy to study medications or hypersensitive to local anesthetics
- Contraindicated for neuraxial anesthesia
- Inability to self-report pain
- Chronic opioid used
Key Trial Info
Start Date :
December 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06153602
Start Date
December 7 2023
End Date
November 28 2024
Last Update
January 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University
Pathum Wan, Bangkok, Thailand, 10330